Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.3171
-0.0131 (-3.97%)
At close: Oct 13, 2025, 4:00 PM EDT
0.3199
+0.0028 (0.88%)
After-hours: Oct 13, 2025, 6:32 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $15.70 million as of October 13, 2025. Its market cap has decreased by -84.45% in one year.
Market Cap
15.70M
Enterprise Value
24.57M
1-Year Change
-84.45%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $15.70M, a decrease of -95.51%. That is a compound annual growth rate of -58.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 16.35M | -81.69% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.82B |
| Johnson & Johnson | 458.19B |
| AbbVie | 410.58B |
| UnitedHealth Group | 324.00B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.41B |